Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 51,875Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1MSD INTL GMBH

02 4Merck & Co

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Cilastatin Sodium; Imipenem Monohydrate; Relebactam Monohydrate

Brand Name : Recarbrio

Dosage Form : Solution For Injection

Dosage Strength : 500mg;500mg;250mg

Packaging :

Approval Date : 13/02/2020

Application Number : 20181109000062

Regulatory Info : Approved

Registration Country : Sweden

blank

02

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Imipenemmonohydrat; Cilastatinnatrium; Relebaktammonohydrat

Brand Name : Recarbrio

Dosage Form : Powder For Infusion Solution

Dosage Strength : 500mg; 500mg; 250mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

03

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Imipenem; Cilastatin; Relebactam

Brand Name : Recharge

Dosage Form : Solution For Injection

Dosage Strength : 500mg/vial; 500mg/vial; 250mg/vial

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

04

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Cilastatin Sodium; Imipenem Monohydrate; Relebactam Monohydrate

Brand Name : Recarbrio

Dosage Form : Solution For Injection

Dosage Strength : 500mg; 500mg; 250mg

Packaging :

Approval Date : 13-02-2020

Application Number : 28106192418

Regulatory Info : Prescription

Registration Country : Denmark

blank

05

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

Brand Name : RECARBRIO

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 500MG BASE/VIAL;500MG/VIAL;250MG/VIAL

Packaging :

Approval Date : 2019-07-16

Application Number : 212819

Regulatory Info : RX

Registration Country : USA

blank